AI could spot sepsis before It's too late
NCT ID NCT07543497
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a new AI tool called Sepsis ImmunoScore that helps doctors quickly identify patients at risk of sepsis. Researchers will enroll 5,000 adults in U.S. hospitals to see if the tool improves diagnosis and speeds up treatment. The goal is to reduce serious complications and save lives.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Sepsis ImmunoScore (AI-based diagnostic test)
- What this could lead to
- If successful, this AI tool could help doctors spot sepsis earlier, leading to faster treatment and better survival.
- What could go wrong
- This is an early-stage device study, not a treatment trial. The tool may not improve outcomes in real-world settings.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEPSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can we optimize antibiotic dosing for children with sepsis?
- Could starting feeds sooner shield preterm babies from infection?
- Can brain waves predict thinking problems after sepsis?
- Can tailored nutrition boost recovery in the ICU?
- Blood markers may foretell brain fog after sepsis
- A hidden clue in the fingertips: could a pulse oximeter reading forecast sepsis outcomes?